- Home
- NAUT vs TSVT Comparison
NAUT vs TSVT Comparison
Compare NAUT & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- TSVT
- Stock Information
- Founded
- NAUT 2016
- TSVT 2021
- Country
- NAUT United States
- TSVT United States
- Employees
- NAUT N/A
- TSVT 425
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- NAUT Industrials
- TSVT Health Care
- Exchange
- NAUT Nasdaq
- TSVT Nasdaq
- Market Cap
- NAUT 284.7M
- TSVT 268.3M
- IPO Year
- NAUT N/A
- TSVT N/A
- Fundamental
- Price
- NAUT $2.78
- TSVT $5.23
- Analyst Decision
- NAUT Buy
- TSVT Buy
- Analyst Count
- NAUT 2
- TSVT 6
- Target Price
- NAUT $4.50
- TSVT $10.40
- AVG Volume (30 Days)
- NAUT 62.8K
- TSVT 294.1K
- Earning Date
- NAUT 10-29-2024
- TSVT 11-12-2024
- Dividend Yield
- NAUT N/A
- TSVT N/A
- EPS Growth
- NAUT N/A
- TSVT N/A
- EPS
- NAUT N/A
- TSVT N/A
- Revenue
- NAUT N/A
- TSVT $44,120,000.00
- Revenue This Year
- NAUT N/A
- TSVT N/A
- Revenue Next Year
- NAUT N/A
- TSVT $22.42
- P/E Ratio
- NAUT N/A
- TSVT N/A
- Revenue Growth
- NAUT N/A
- TSVT N/A
- 52 Week Low
- NAUT $2.19
- TSVT $1.54
- 52 Week High
- NAUT $3.46
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- NAUT 49.56
- TSVT 55.94
- Support Level
- NAUT $2.62
- TSVT $4.86
- Resistance Level
- NAUT $3.03
- TSVT $5.03
- Average True Range (ATR)
- NAUT 0.13
- TSVT 0.18
- MACD
- NAUT -0.00
- TSVT 0.01
- Stochastic Oscillator
- NAUT 42.25
- TSVT 79.00
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.